Your browser doesn't support javascript.
loading
Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system.
Simko, Fedor; Stanko, Peter; Repova, Kristina; Baka, Tomas; Krajcirovicova, Kristina; Aziriova, Silvia; Domenig, Oliver; Zorad, Stefan; Adamcova, Michaela; Paulis, Ludovit.
Afiliación
  • Simko F; Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava 81108, Slovak Republic; 3rd Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava 83305, Slovak Republic; Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Aca
  • Stanko P; Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava 81108, Slovak Republic; Department of Pneumology, Phthisiology and Functional Diagnostics, Slovak Medical University and Bratislava University Hospital, Bratislava, Slovak Republic.
  • Repova K; Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava 81108, Slovak Republic.
  • Baka T; Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava 81108, Slovak Republic.
  • Krajcirovicova K; Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava 81108, Slovak Republic.
  • Aziriova S; Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava 81108, Slovak Republic.
  • Domenig O; Attoquant Diagnostics, Vienna 1110, Austria.
  • Zorad S; Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava 84505, Slovak Republic.
  • Adamcova M; Department of Physiology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove 50003, Czech Republic.
  • Paulis L; Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava 81108, Slovak Republic; Centre of Experimental Medicine SAS, Institute of Normal and Pathological Physiology, Slovak Academy of Sciences, Bratislava 813 71, Slovak Republic.
Biomed Pharmacother ; 173: 116391, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38461685
ABSTRACT
This study investigated whether sacubitril/valsartan or valsartan are able to prevent left ventricular (LV) fibrotic remodelling and dysfunction in two experimental models of pre-hypertension induced by continuous light (24 hours/day) exposure or by chronic lactacystin treatment, and how this potential protection interferes with the renin-angiotensin-aldosterone system (RAAS). Nine groups of three-month-old male Wistar rats were treated for six weeks as follows untreated controls (C), sacubitril/valsartan (ARNI), valsartan (Val), continuous light (24), continuous light plus sacubitril/valsartan (24+ARNI) or valsartan (24+Val), lactacystin (Lact), lactacystin plus sacubitil/valsartan (Lact+ARNI) or plus valsartan (Lact+Val). Both the 24 and Lact groups developed a mild but significant systolic blood pressure (SBP) increase, LV hypertrophy and fibrosis, as well as LV systolic and diastolic dysfunction. Yet, no changes in serum renin-angiotensin were observed either in the 24 or Lact groups, though aldosterone was increased in the Lact group compared to the controls. In both models, sacubitril/valsartan and valsartan reduced elevated SBP, LV hypertrophy and fibrosis and attenuated LV systolic and diastolic dysfunction. Sacubitril/valsartan and valsartan increased the serum levels of angiotensin (Ang) II, Ang III, Ang IV, Ang 1-5, Ang 1-7 in the 24 and Lact groups and reduced aldosterone in the Lact group. We conclude that both continuous light exposure and lactacystin treatment induced normal-to-low serum renin-angiotensin models of pre-hypertension, whereas aldosterone was increased in lactacystin-induced pre-hypertension. The protection by ARNI or valsartan in the hypertensive heart in either model was related to the Ang II blockade and the protective Ang 1-7, while in lactacystin-induced pre-hypertension this protection seems to be additionally related to the reduced aldosterone level.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Acetilcisteína / Prehipertensión / Aminobutiratos / Insuficiencia Cardíaca / Hipertensión Límite: Animals Idioma: En Revista: Biomed Pharmacother Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Acetilcisteína / Prehipertensión / Aminobutiratos / Insuficiencia Cardíaca / Hipertensión Límite: Animals Idioma: En Revista: Biomed Pharmacother Año: 2024 Tipo del documento: Article